Standout Papers

Disulfidptosis: a new target for metabolic cancer therapy 2022 2026 2023 2024185
  1. Disulfidptosis: a new target for metabolic cancer therapy (2023)
    Peijie Zheng, Yuemin Ding et al. Journal of Experimental & Clinical Cancer Research
  2. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy (2022)
    Peijie Zheng, Liuyi Lu et al. Journal of Experimental & Clinical Cancer Research

Immediate Impact

2 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

A Self‐Amplifying ROS‐Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy
2024 Standout
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
2024 Standout
1 intermediate paper

Works of Yuemin Ding being referenced

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
2022 Standout

Author Peers

Author Last Decade Papers Cites
Yuemin Ding 341 77 60 169 167 26 663
Eun-Jin Yun 431 25 86 202 163 24 759
Asta Pirskanen 459 67 105 79 88 25 806
Satoshi Sugita 506 34 69 193 106 38 750
Yang Liu 539 32 39 222 118 36 815
Angelo Sparaneo 396 45 32 107 111 39 703
Marina Trombetta-Lima 367 69 44 117 87 38 742
Eric Van Buren 364 65 62 115 66 33 801
Yiming Tu 470 23 39 183 147 32 777
Valentina Sala 431 36 42 100 84 24 847
Yang Wang 428 77 23 122 116 46 779

All Works

Loading papers...

Rankless by CCL
2026